Choice of Renal Function Estimator Influences Adverse Outcomes with Dabigatran Etexilate in Patients with Atrial Fibrillation

Background  Clinical significance of dosing dabigatran with different estimates of renal function for treatment of atrial fibrillation (AF) is unknown. Renal function is routinely estimated by the chronic kidney disease epidemiology initiative equation (CKD-EPI) and used to guide dosing. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Bryan H., Reith, David M., Medlicott, Natalie J., Smith, Alesha J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524914/
https://www.ncbi.nlm.nih.gov/pubmed/31249970
http://dx.doi.org/10.1055/s-0038-1676356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524914/
https://www.ncbi.nlm.nih.gov/pubmed/31249970
http://dx.doi.org/10.1055/s-0038-1676356

Ejemplares similares